Scandidos
1.62
SEK
-1.82 %
SDOS
First North Stockholm
Medical Equipment & Services
Health Care
Be the first to follow this company
-1.82%
-2.41%
-6.9%
-1.82%
-8.47%
-20.2%
-12.9%
-52.91%
-57.59%
-88.28%
scandidos.com/investors
Scandidos are active in medical technology. The company provides products and systems for quality assurance of advanced radiation therapy against cancer. The systems analyze the radiation dose before and during ongoing radiation treatment. The company was founded in 2002 and the first product was launched in 2006. Since its inception, Scandidos has delivered products to radiation therapy clinics on a global level. The head office is located in Uppsala.
Revenue
60.43M
EBIT %
-22.31 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
SDOS
Daily low / high price
1.62 / 1.62
SEK
Market cap
92.36M SEK
Turnover
202.5 SEK
Volume
125
Latest videos
Financial calendar
Interim report
2024-12-17
Interim report
2025-03-12
Annual report
2025-06-18
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Spore Invest AB | 29.5 % | 29.5 % |
| Commerzbank AG, W8IMY - IBA Dosimetry | 10.1 % | 10.1 % |
| Avanza Pension | 6.0 % | 6.0 % |
| Tullbacken | 5.2 % | 5.2 % |
| Görgen Stjernfeldt Nilsson | 4.2 % | 4.2 % |
| Ingemar Wiberg | 4.1 % | 4.1 % |
| Henning Kenneth Holmström | 3.9 % | 3.9 % |
| Hans Mathias Johansson | 3.7 % | 3.7 % |
| Nordnet pensionsförsäkring AB | 2.7 % | 2.7 % |
| Reviosonsfirma Jens Kristian Jepsen | 2.0 % | 2.0 % |
ShowingAll content types
ScandiDos Expands with New Reference Center in Madrid, Spain
KOMMUNIKÉ FRÅN ÅRSSTÄMMA I SCANDIDOS AB (PUBL)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools